Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $44.5M | $63.1M | $71.0M | $59.7M | $55.1M | $61.2M |
| Revenue growth | — | 41.8% | 12.5% | -16.0% | -7.6% | 11.1% |
| Operating income | $7.85M | -$34.9M | -$27.5M | -$2.07M | -$13.7M | -$8.17M |
| Operating margin | 17.6% | -55.2% | -38.8% | -3.5% | -24.8% | -13.3% |
| Net income | $5.28M | -$44.0M | -$29.6M | -$3.85M | -$14.7M | -$11.4M |
| Net margin | 11.9% | -69.7% | -41.7% | -6.5% | -26.6% | -18.7% |
| EPS (diluted) | $0.49 | -$4.32 | -$1.69 | -$0.21 | -$0.72 | -$0.47 |
| Fiscal year | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | $5.13M | -$2.18M | -$13.5M | $5.24M | -$9.13M | -$12.4M |
| Capital expenditures | — | — | $20.0M | $5.00M | $15.0M | — |
| Free cash flow | — | — | -$33.5M | $240K | -$24.1M | — |
| Fiscal year | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $8.25M | $49.1M | $32.0M | $27.4M | $20.3M | $24.1M |
| Total assets | $51.9M | $97.3M | $105M | $76.8M | $80.2M | $94.6M |
| Total liabilities | $41.6M | $55.2M | $88.2M | $56.5M | $60.2M | $62.7M |
| Long-term debt | — | — | $19.8M | $14.6M | $24.9M | $25.3M |
| Shareholders' equity | $10.3M | $42.0M | $17.0M | $20.4M | $20.1M | $31.9M |
| Retained earnings | $5.12M | -$38.9M | -$68.5M | -$72.4M | -$87.0M | -$98.5M |
| Shares (wtd avg diluted) | 10.8M | 10.2M | 17.5M | 18.2M | 20.4M | 24.5M |
Every figure is extracted from Journey Medical Corp’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.